For the Inventor, By the Inventor

Enter assignee name

Raleigh, NC, United States of America

Liposcience, Inc.

Calculating rank

USPTO Granted Patents = 35

% Expired Patents = 8.6

CIPO Patents = 3

EPO Patents = 12

Trademarks = 5

Forward Citations = 229

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

James D Otvos (33 out of 41 patents)

Irina Y Shalaurova (18 out of 21 patents)

Elias J Jeyarajah (11 out of 12 patents)

4. Dennis W Bennett (11 out of 14 patents)

5. Justyna E Wolak-Dinsmore (10 out of 11 patents)

6. Thomas M O'Connell (8 out of 8 patents)

7. Steven P Matyus (7 out of 7 patents)

8. David R Morgan (5 out of 5 patents)

9. Stephen Markham (4 out of 4 patents)

10. Bruce D Silberman (4 out of 4 patents)

11. Donald R Deuel (4 out of 4 patents)

12. Kelly Mercier (4 out of 4 patents)

13. Stanley Leon Hazen (3 out of 59 patents)

14. Stanley L Hazan (1 out of 1 patent)

15. Russell Reeve (1 out of 1 patent)

Core Competencies:

NMR Technology

Metabolic Vulnerability

Diabetes Risk Evaluation

Cardiovascular Risk

HDL Particle Number

Biosample Analysis

Lipoprotein Insulin Resistance

TMAO Quantification

GlycA Biomarker

CHD Risk Stratification

Multiple-Marker Parameters

Personalized Risk Assessments

35 patents: Sort by Forward Citations

1. 12130295 - NMR system and methods for multi-parameter metabolic vulnerability index evaluations (2024-10-29),

2. 11990243 - Multiple-marker risk parameters predictive of conversion to diabetes (2024-05-21),

3. 11988679 - Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter (2024-05-21),

4. 11942187 - Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements (2024-03-26),

5. 11782002 - NMR quantification of TMAO (2023-10-10),

6. 11710568 - Multi-parameter diabetes risk evaluations (2023-07-25),

7. 11703501 - CHD risk stratification evaluations for subjects with high levels of large HDL-P (2023-07-18),

8. 11231429 - Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter (2022-01-25),

9. 11156685 - NMR analyzers for clinical evaluation of biosamples (2021-10-26),

10. 11156621 - Multi-parameter metabolic vulnerability index evaluations (2021-10-26),

11. 11037683 - Multiple-marker risk parameters predictive of conversion to diabetes (2021-06-15),

12. 10852293 - NMR measurements of NMR biomarker GlycA (2020-12-01),

13. 10613044 - NMR quantification of TMAO (2020-04-07),

14. 10504610 - Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements (2019-12-10),

15. 10388414 - Multi-parameter diabetes risk evaluations (2019-08-20),

Company Overview

Liposcience, Inc. is a biotechnology company based in Raleigh, North Carolina, specializing in advanced diagnostic solutions. The organization focuses on developing innovative technologies for the analysis of lipoproteins and other biomarkers, aiming to enhance the understanding of cardiovascular health. Liposcience's research is pivotal in the field of personalized medicine, providing insights that assist healthcare professionals in making informed decisions regarding patient care and treatment strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

35 Patents

#23 in Raleigh, NC

#230 in North Carolina

#9,757 in US

#19,187 in the World

Raleigh, NC, United States of America

Liposcience, Inc.

Forward Citations = 229

15 inventors:

James D Otvos (33 out of 41 patents)

Irina Y Shalaurova (18 out of 21 patents)

Elias J Jeyarajah (11 out of 12 patents)

4. Dennis W Bennett (11 out of 14 patents)

5. Justyna E Wolak-Dinsmore (10 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Liposcience, Inc.. Retrieved from https://idiyas.com/company/liposcience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…